LSX World Congress – Day One
R&D
Day One will kick off with a couple of sessions on the investing landscape, including one featuring speakers from Google and Eli Lilly.
But the highlight of the morning should be a speech by Astellas’ chief medical officer, Tadaaki Taniguchi, who will speak about the importance of collaboration and partnership in a rapidly changing treatment landscape.
Stay tuned throughout the afternoon to hear from VCs at Novartis, Pfizer, and Boehringer Ingelheim about strategic investing, plus panels on AI and clinical trials.
